Peter Schmidt - 06 Dec 2022 Form 3 Insider Report for Invivyd, Inc. (IVVD)

Reporting relationship: Chief Medical Officer
Issuer ticker: IVVD
Reported as of: 06 Dec 2022
Net transaction value: $0
SEC form: 3
Accepted by SEC: 06 Dec 2022, 16:52:03 UTC
Next SEC filing: 16 Dec 2022
Source filing: View source filing
Reporting owner signature: /s/ Jill Andersen attorney-in-fact for Peter Schmidt

Key filing fact

Peter Schmidt filed Form 3 for Invivyd, Inc. (IVVD) on 06 Dec 2022.

Key facts

This page summarizes Peter Schmidt's Form 3 filing for Invivyd, Inc. (IVVD).
0 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 06 Dec 2022, 16:52.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IVVD holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 6,971
Date: 06 Dec 2022
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IVVD holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 06 Dec 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 112,900
Exercise price: $4.61
Footnotes: F1

IVVD holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 06 Dec 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 73,800
Exercise price: $6.39
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This option vests over a four-year period, with 25% of the shares subject to the option vesting on the first anniversary of the grant date of January 13, 2021, and 1/48th of the total shares subject to the option vesting in substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service as of each vesting date.

Footnote F2

This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date of February 14, 2022, subject to the Reporting Person's continuous service as of each vesting date.

SEC remarks

Exhibit 24.1: Power of Attorney